Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18.5M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
11.4M
-
Shares change
-
-1.03M
-
Total reported value, excl. options
-
$55.3M
-
Value change
-
-$15.7M
-
Put/Call ratio
-
1.95
-
Number of buys
-
47
-
Number of sells
-
-35
-
Price
-
$4.86
Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q4 2024
104 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q4 2024.
OptimizeRx Corp - Common Stock (OPRX) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.4M shares
of 18.5M outstanding shares and own 61.4% of the company stock.
Largest 10 shareholders include Whetstone Capital Advisors, LLC (1.35M shares), BlackRock, Inc. (1.34M shares), ROYCE & ASSOCIATES LP (1.07M shares), VANGUARD GROUP INC (936K shares), BLAIR WILLIAM & CO/IL (601K shares), KENNEDY CAPITAL MANAGEMENT LLC (594K shares), RICE HALL JAMES & ASSOCIATES, LLC (578K shares), DIMENSIONAL FUND ADVISORS LP (444K shares), GEODE CAPITAL MANAGEMENT, LLC (401K shares), and STATE STREET CORP (357K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.